Alternative approaches in IVF

Human Reproduction Update

Volumn 8, Issue 1, 2002, Pages 1-9

  Fauser, Bart C J M ^a   Bouchard, Philippe ^b   Bennink, Herjan J T Coelingh ^c   Collins, John A ^d   Devroey, Paul ^e   Evers, Johannes L H ^f   Van Steirteghem, Andre ^e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HÔPITAL SAINT ANTOINE   (France)

^c NV ORGANON   (Netherlands)

^d McMaster Diversity   (Canada)

^e CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cryopreservation; Embryo culture; Follicle development; IVF health economics; Ovarian stimulation

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; CLOMIFENE; FOLLITROPIN; GANIRELIX; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ARTICLE; CELL CULTURE; CLINICAL PROTOCOL; CONTROLLED STUDY; CRYOPRESERVATION; DRUG COST; EMBRYO; EMBRYO CULTURE; FERTILIZATION IN VITRO; HEALTH ECONOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; OOCYTE; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; REGULATORY MECHANISM; SCIENCE; STIMULATION;

CELLS, CULTURED; CRYOPRESERVATION; CULTURE TECHNIQUES; EMBRYO; FEMALE; FERTILIZATION IN VITRO; HEALTH CARE COSTS; HUMANS; OOCYTES; OVARIAN FOLLICLE; OVULATION INDUCTION;

EID: 0036168829     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/8.1.1     Document Type: Article

References (65)

1. Blastocyst culture and transfer
2. Gonadotropin-releasing hormone antagonist: New tools vs. old habits
3. First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males
4. Chemical structure of sterols that activate oocyte meiosis
5. Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome
6. Cryopreservation of mature human oocytes by vitrification with ethylene glycol in straws
7. The economic consequences of multiple gestation pregnancy in assisted conception cycles
8. The cost of infertility diagnosis and treatment in Canada in 1995
9. Monozygotic twins and transfer at the blastocyst stage after ICSI
10. GnRH agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles
11. Recombinant versus urinary FSH for ovarian stimulation in assisted reproduction
12. High dose GnRH antagonist may prevent OHSS caused by ovarian stimulation for IVF
13. Growth differentiation factor-9 is required during early ovarian folliculogenesis
14. Long-term effects of embryo freezing in mice
15. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse
16. Manipulation of human ovarian function: Physiological concepts and clinical consequences
17. Minimal ovarian stimulation for IVF: Appraisal of potential benefits and drawbacks
18. Clinical review 126: Roles and novel regimens of luteinizing hormone and follicle-stimulating hormone in ovulation induction
19. Mutation in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner
20. A prospective randomized trial of blastocyst culture and transfer in in-vitro fertilization
21. Blastocyst score affects implantation and pregnancy outcome: Towards a single blastocyst transfer
22. The in vivo and in vitro efficiency and efficacy of PGD for aneuploidy
23. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: A randomised trial and cost-effectiveness analysis
24. Financing of IVF/ET in the Nordic countries
25. Hormonal regulation of early follicle development in the rat ovary
26. Induction of preovulatory LH surge and prevention of ovarian hyperstimulation syndrome by GnRH agonist
27. Blastocyst stage transfer: Pitfalls and benefits. The benefits of extended culture
28. Cryopreservation: The problem of evaluation
29. Prospective randomized trial comparing the outcome and cost of in vitro fertilization with that of a traditional treatment algorithm as first-line therapy for couples with infertility
30. Cocultured blastocyst cryopreservation: Experience of more than 500 transfer cycles
31. Mutations of follicle-stimulating hormone-beta and its receptors in human and mouse: Genotype/phenotype
32. Cryopreservation of cattle oocytes: Effects of meiotic stage, cycloheximide treatment, and vitrification procedure
33. The use of rec LH, GnRH agonist or hCG to trigger ovulation
34. Cryopreservation in human assisted reproduction is now routine for embryos but remains a research procedure for oocytes
35. Revelations of ovarian follicle biology from gene knock out mice
36. Initial and cyclic recruitment of ovarian follicles
37. Control of ovarian follicular development
38. Assisted reproductive technology (ART) in humans: Facts and uncertainties
39. Targeted expression of Bcl-2 in mouse oocytes inhibits ovarian follicle atresia and prevents spontaneous and chemotherapy-induced oocyte apoptosis in vitro
40. Chromosome abnormalities in human embryos
41. The cost of a successful delivery with in vitro fertilization
42. Nuclear status and cytogenetics of embryos derived from in vitro-matured oocytes
43. Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary
44. Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency
45. Evaluation of the relative cost-effectiveness of treatments for infertility in the UK
46. From oocyte to embryo: A model, deduced from in vitro fertilization, for natural selection against chromosome abnormalities
47. The predictive value of day 3 embryo morphology regarding blastocyst formation, pregnancy and implantation rate after day 5 transfer following in-vitro fertilization or intracytoplasmic sperm injection
48. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: An application to in vitro fertilization
49. Developmental ability of chromosomally abnormal human embryos to develop to the blastocyst stage
50. Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients
51. Fundamental cryobiology of mammalian oocytes and ovarian tissue
52. The potential association between blastocyst transfer and monozygotic twinning
53. In-utero overgrowth in ruminants following embryo culture: Lessons from mice and a warning to men
54. Epidermal growth factor combined with recombinant human chorionic gonadotrophin improves meiotic progression in mouse follicle-enclosed oocyte culture
55. Ovarian response in women to recombinant follicle stimulating hormone and luteinizing hormone: A role for LH in the final stages of follicular maturation
56. Results of in-vitro fertilisation with embryo cryopreservation and a recommendation for uniform reporting
57. Calculating the implantation potential of day 3 embryos in women younger than 38 years of age: A new model
58. Significantly enhanced pregnancy rates through cryopreservation and thaw of pronuclear stage oocytes
59. Laser blastocyst biopsy for preimplantation diagnosis in the human
60. Androgens promote insulin-like growth factor I expression and initiation of follicle development in the primate ovary
61. Obstetric and perinatal outcome of children conceived from cryopreserved embryos
62. Postnatal growth and health of children born after cryopreservation as embryos
63. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction
64. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function
65. Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture